Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. S. J. Arner

HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11c-Labeled Sel-Tagged Affibody Molecule

Journal of Nuclear Medicine

English

Active Sites of Thioredoxin Reductases: Why Selenoproteins?

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2003

English

Related publications

Cy5.5-Labeled Affibody Molecule for Near-Infrared Fluorescent Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors

Journal of Biomedical Optics

Biomedical Engineering

2010

English

In Vivo Targeting of HER2-positive Tumor Using 2-Helix Affibody Molecules

Amino Acids

Organic Chemistry

Biochemistry

Clinical Biochemistry

2011

English

On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124i-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

Journal of Nuclear Medicine

English

All HER2-Positive Tumors Are Not Created Equal

Annals of Surgical Oncology

Oncology

Surgery

2017

English

Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment

Journal of Nuclear Medicine

English

In Vivo Studies of Acetylcholinesterase Activity Using a Labeled Substrate,N-[11C]methylpiperdin-4-Yl Propionate ([11C]PMP)

Synapse

Molecular Neuroscience

Cellular

1996

English

Adenovirus 5 Vector Genetically Re-Targeted by an Affibody Molecule With Specificity for Tumor Antigen HER2/neu

English

Biodistribution and Radiation Dosimetry of the Anti-Her2 Affibody Molecule 68Ga-Aby-025 in Breast Cancer Patients

Journal of Nuclear Medicine

English

In VivoandIn VitroStudies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors

Cancer Biotherapy and Radiopharmaceuticals

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. S. J. Arner

HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11c-Labeled Sel-Tagged Affibody Molecule

Active Sites of Thioredoxin Reductases: Why Selenoproteins?

Related publications

Cy5.5-Labeled Affibody Molecule for Near-Infrared Fluorescent Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors

In Vivo Targeting of HER2-positive Tumor Using 2-Helix Affibody Molecules

On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124i-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model

All HER2-Positive Tumors Are Not Created Equal

Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment

In Vivo Studies of Acetylcholinesterase Activity Using a Labeled Substrate,N-[11C]methylpiperdin-4-Yl Propionate ([11C]PMP)

Adenovirus 5 Vector Genetically Re-Targeted by an Affibody Molecule With Specificity for Tumor Antigen HER2/neu

Biodistribution and Radiation Dosimetry of the Anti-Her2 Affibody Molecule 68Ga-Aby-025 in Breast Cancer Patients

In VivoandIn VitroStudies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors